FDA Inspection
Andapharm, LLCAndapharm, LLC – FDA Inspection, Feb 7, 2012
Record Details
This FDA Inspection record concerns Andapharm, LLC, with an inspection on February 7, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Andapharm, LLC
- Inspection Date
- February 7, 2012
- Product Type
- Drugs
View Company Profile
ID · 89f52d14-491f-42ee-a275-4b2d73793cbd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 764765
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Andapharm, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2016 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| August 7, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Andapharm, LLC
- FDA Inspection 1059714 - 2018-07-18
- FDA Inspection 961715 - 2016-02-26
- FDA Inspection 602314 - 2009-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.